Legal Representation
Attorney
Michael K. Kinney
USPTO Deadlines
Next Deadline
1708 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240924)
Due Date
September 24, 2030
Grace Period Ends
March 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 24, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 24, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 20, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 20, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 17, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 17, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 17, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 17, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 1, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 2, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 1, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 2, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 26, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 31, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 31, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 11, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 23, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 12, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 11, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 11, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 20, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 20, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 20, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 27, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 6, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 6, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 6, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 6, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 30, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 19, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and drug development using artificial intelligence; Pharmaceutical research and drug development of biological macromolecules and multi-specific molecules; conducting early evaluations in the field of new pharmaceutical drugs using artificial intelligence; computer software design for pharmaceutical research and drug development using artificial intelligence; development of computer platforms for pharmaceutical research and drug development using artificial intelligence; research in the field of artificial intelligence technology for pharmaceutical drug development
First Use Anywhere:
Jan 28, 2019
First Use in Commerce:
Dec 1, 2019
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"